Suchergebnisse - "Smith, Patrick F"

PubPharm (21)

1

An evaluation of a supratherapeutic dose of inclisiran on cardiac repolarization in healthy volunteers : A phase I, randomized study

enthalten in: Clinical and translational science | 2022

von Kallend, D. | Mason, J. | Smith, P. | +4

2

A thorough QTc study to evaluate the effects of oral rilzabrutinib administered alone and with ritonavir in healthy subjects

enthalten in: Clinical and translational science | 2022

von Ucpinar, S. | Darpo, B. | Neale, A. | +8

3

Phase 1 clinical trial evaluating safety, exposure and pharmacodynamics of BTK inhibitor tolebrutinib (PRN2246, SAR442168)

enthalten in: Clinical and translational science | 2022

von Owens, T. | Smith, P. | Redfern, A. | +8

4

Clinical and virological responses to a broad-spectrum human monoclonal antibody in an influenza virus challenge study

enthalten in: Antiviral research | 2020

von Sloan, S. | Szretter, K. | Sundaresh, B. | +7

5

Respiratory syncytial virus-A dynamics and the effects of lumicitabine, a nucleoside viral replication inhibitor, in experimentally infected humans

enthalten in: The Journal of antimicrobial chemotherapy | 2019

von Patel, K. | Kirkpatrick, C. | Nieforth, K. | +10

6

A phase I trial of PRN1008, a novel reversible covalent inhibitor of Bruton's tyrosine kinase, in healthy volunteers

enthalten in: British journal of clinical pharmacology | 2017

von Smith, P. | Krishnarajah, J. | Nunn, P. | +6

7

Safety and Upper Respiratory Pharmacokinetics of the Hemagglutinin Stalk-Binding Antibody VIS410 Support Treatment and Prophylaxis Based on Population Modeling of Seasonal Influenza A Outbreaks

enthalten in: EBioMedicine | 2016

von Wollacott, A. | Boni, M. | Szretter, K. | +8

CommentIn: EBioMedicine. 2016 Mar;5:16-7. - PMID 27077102

8

Modelling the interaction between danoprevir and mericitabine in the treatment of chronic HCV infection

enthalten in: Antiviral therapy | 2016

von Canini, L. | Guedj, J. | Chatterjee, A. | +3

9

A pharmacokinetic/viral kinetic model to evaluate the treatment effectiveness of danoprevir against chronic HCV

enthalten in: Antiviral therapy | 2015

von Canini, L. | Chatterjee, A. | Guedj, J. | +4

10

Pharmacokinetics and pharmacodynamics of setrobuvir, an orally administered hepatitis C virus non-nucleoside analogue inhibitor

enthalten in: Clinical therapeutics | 2014

von Mallalieu, N. | Rahimy, M. | Crowley, C. | +3